STOCK TITAN
  1. Home
  2. XON

XON Stock Price, News & Analysis

XON

Company Description

XON (Nasdaq: XON) is a publicly traded company.

XON stock has declined 39.3% over the past year.

This page provides a comprehensive overview of XON stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-39.3%
Performance 1 year
$0.0
Market Cap
0.0
Shares outstanding

XON (XON) stock. Over the past 12 months, the stock has lost 39.3%.

Latest News

View All
—

Biotech Company Allonnia Appoints Lieutenant General (Ret.) Thomas P. Bostick to Board of Directors; Celebrates Additions to Advisory Team

management
—

Precigen Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

offering
—

Precigen to Present at the 39th Annual J.P. Morgan Healthcare Conference

conferences
—

Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results

earnings
—

Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December

earnings

XON has 5 recent news articles. Key topics include management, offering, conferences, earnings. View all XON news →

SEC Filings

View All

No SEC filings available for XON.

Financial Highlights

—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months